An interventional study of Internet-based CBT intervention in Myocardial Infarction, sponsored by Per Tornvall. Recruiting at 1 site in Sweden. Open to participants aged 35 Years to 79 Years. Per ClinicalTrials.gov, last updated 2025-03-07.
Sponsored by Per Tornvall · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 90 studies in Myocardial Infarction with a site in Sweden — 13 open to participants now, 22 under way, 4 of them phase 3. Myocardial Infarction · Sweden.
Among the 90 studies in Myocardial Infarction with a site in Sweden, this one is the 61st largest by planned enrollment of the 70 interventional ones that give a count, is one of 6 that started in 2021, is one of 23 with no phase, reaches primary completion later than 2 of the 21 other live ones, and was the 61st registered.
2,272 studies on the registry are indexed under Myocardial Infarction; 371 are open to participants now.
Browse Myocardial Infarction studies →13 of the 90 studies in Myocardial Infarction with a site in Sweden are open now. Recruiting first, the newest first:
Uppsala University · Sites in Sweden
Ages 18–55
Abcentra · Sites in Sweden, United States, Czechia and 6 more countries
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+ · Healthy volunteers
Karolinska Institutet · Sites in Sweden
Ages 18+
Uppsala University · Sites in Sweden
Ages 50–80
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 255 Myocardial Infarction studies recruiting now, 172 (67%) set no upper age limit and 26 (10%) stop at 75 or younger; 16 take children under 18; 27 take healthy volunteers.
This study: 35 Years to 79 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 11 · Phase 3 26 · Phase 4 11
First in 1997; this study’s year is marked. 6 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 64 is below the median of 150 across 1,314 interventional studies indexed under Myocardial Infarction.
Median enrollment 875 across the 70 interventional studies, 5,518 across the 20 observational. Of the 64 that completed or were terminated, 21 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
38 of 90 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Per Tornvall as lead sponsor.
Per Tornvall has 1 study filed under Myocardial Infarction — fewer than ten, so there is no comparison to draw.
6 of the studies in Myocardial Infarction with a site in Sweden that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04957719Phase 3Viatris Innovation GmbHSelatogrel Outcome Study in Suspected Acute Myocardial Infarction | 2027-07 |
| NCT05889416Skane University HospitalThe Perfect-CR Implementation Study | 2026-12 |
| NCT03620266Ole Frobert, MD, PhDEffects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI | 2026-12-31 |
| NCT07706816Uppsala UniversityEvaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study | 2027-01-31 |
| NCT06927739AbcentraFocused Orticumab Research for Treating Inflammation in Coronary Arteries | 2027-02-08 |
Add all 6 to your calendar (.ics) → With an account.
Among the 90 studies in Myocardial Infarction with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome often have high levels of stress and anxiety. At present there are no treatment alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT), primarily aiming at relieving stress, has been shown to decrease morbidity in patient with myocardial infarction with obstructive coronary arteries. The present open randomized study aims to decrease stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on stress and anxiety.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A nine step internet-based intervention with focus on stress and anxiety
Behavioral: Internet-based CBT intervention
Regular follow-up with two doctor and one nurse appointment
A nine step intervention including internet-based feedback by psychologists
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)
Normalisation of PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)
Time frame: 12-14 weeks after the acute event
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)
Normalisation of HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)
Time frame: 12-14 weeks after the acute event
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)
PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)
Time frame: 10, 20 and 50 weeks after randomisation
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)
HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)
Time frame: 10, 20 and 50 weeks after randomisation
Self-rated quality-of-life determined by Research ANd Development-36 (RAND-36)
RAND-36: 0-100 with high numbers indicating better quality-of-life
Time frame: 10, 20 and 50 weeks after randomisation
Self-rated cardiac anxiety determined by Cardiac Anxiety Questionnaire (CAQ)
CAQ: 0-72 with high numbers indicating increased cardiac anxiety
Time frame: 10, 20 and 50 weeks after randomisation
Self-rated post-traumatic symptoms determined by Impact of Event Scale-6 (IES-6)
IES-6: 0-30 with high numbers indicating increased post-traumatic symptoms
Time frame: 10, 20 and 50 weeks after randomisation
Sick leave
Self-reported total number of days
Time frame: 10, 20 and 50 weeks after randomisation
Health-care visits
Self-reported total number of visits
Time frame: 10, 20 and 50 weeks after randomisation
Cortisol in hair
Hair cortisol will be determined by RIA-technique in pg/mg
Time frame: 10 weeks after randomisation
Physiological recovery after stress determined by Heart Rate Variability (HRV)
HRV will be measured by time and frequency domains and by non-linear methods
Time frame: 10 weeks after randomisation
Physiological recovery after stress determined by salivary cortisol
Salivary cortisol will be determined by RIA-technique in pg/mg
Time frame: 10 weeks after randomisation
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2021 to primary completion in Nov 2024, 36 months.
Of 321 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's 36 months is close to that.
Counting every sponsor, half of 354 studies reached it within 34 months; a quarter within 15 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.